ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Legal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,701Medicare Part D Prescriptions Filled, Including Refills
$843K Total Retail Price of All Prescriptions
576 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
SIMVASTATIN 551 534
FUROSEMIDE 322 274
DOXYCYCLINE HYCLATE 307 220
POTASSIUM CHLORIDE 279 202
METFORMIN HCL 226 157
FENOFIBRATE 201 150
LABETALOL HCL 184 165
LOSARTAN POTASSIUM 174 161
LISINOPRIL 167 117
CIPROFLOXACIN HCL 152 112
ALENDRONATE SODIUM 136 136
LEVOTHYROXINE SODIUM 124 115
TRAMADOL HCL 116 72
SULFAMETHOXAZOLE-TRIMETHOPRIM 102 79
NAPROXEN 96 77
SPIRONOLACTONE 96 83
METOLAZONE 96 83
TRIAMTERENE-HCTZ 93 78
GLYBURIDE 87 63 R
TERBINAFINE HCL 86 79
GABAPENTIN 85 66
ALLOPURINOL 82 82
TRIAMCINOLONE ACETONIDE 82 54
LOVASTATIN 77 62
OMEPRAZOLE 75 64
CLOTRIMAZOLE-BETAMETHASONE 71 51
WARFARIN SODIUM 69 61
CEPHALEXIN 68 50
MINOXIDIL 63 63
TAMSULOSIN HCL 63 61
ATORVASTATIN CALCIUM 63 55
PRAVASTATIN SODIUM 61 16
LOSARTAN-HYDROCHLOROTHIAZIDE 57 57
NORVIR 54 0
PENICILLIN V POTASSIUM 53 48
PREDNISONE 53 45
VIREAD 51 11
NAMENDA 51 51
DILTIAZEM 24HR ER 50 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.